42 reports

The company has received approval for tbo-filgrastim (XM## filgrastim).

  • Hormone
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

AMONG THE MAJOR ## MANUFACTURERS, ## IN GUANGDONG PROVINCE, ## IN SHANGHAI, ## IN ZHEJIANG PROVINCE, ## IN ANHUI PROVINCE, ## IN BEIJING AND ## IN HUBEI PROVINCE.

  • Hormone
  • China
  • East Asia
  • Demand
  • Zhejiang Expressway Co., Ltd.

The auto exports exceeded over ## million each year.

  • Hormone
  • China
  • AstraZeneca Pharmaceutical Co., Ltd
  • Bristol-Myers Squibb Company
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
  • 4. Drug/Molecule refers to Primary Intervention only.

The prominent features of this report are - ##.

  • Hormone
  • Maternal Health
  • Therapy
  • World
  • Social Conditions
  • Pituitary Drugs Manufacturers

AMONG THE MAJOR ## MANUFACTURERS, ## IN GUANGDONG PROVINCE, ## IN SHANGHAI, ## IN ZHEJIANG PROVINCE, ## IN ANHUI PROVINCE, ## IN BEIJING AND ## IN HUBEI PROVINCE.

  • Hormone
  • China
  • Pfizer Inc.
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Hormone
  • Maternal Health
  • World
  • Social Conditions
  • Biogen Idec Inc.

Infliximab by Nippon Kayaku (approved in 2014) and Filgrastim by Teva Pharma Japan (approved in 2013) are some of the drugs of this segment.

  • Anti-Infective
  • Hormone
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation
  • Clinical Trial profile. 59 Trial Title

Ovarian Disease Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Ovarian Disease Global Clinical Trials Review, H1, 2018" provides an overview of Ovarian Disease clinical trials scenario.This report provides top line data relating to the clinical trials on Ovarian...

  • Clinical Trial
  • Endocrine Disease
  • Hormone
  • Pharmaceutical
  • World
  • Official Title

Amenorrhea Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Amenorrhea Global Clinical Trials Review, H1, 2017" provides an overview of Amenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Amenorrhea. Report includes an...

  • Genitourinary System Disease
  • Hormone
  • World
  • Product Initiative
  • Repros Therapeutics Inc.
  • Target

Menstrual Disorders Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Menstrual Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Menstrual Disorders clinical trials scenario. This report provides top line data relating to the clinical trials...

  • Clinical Trial
  • Hormone
  • Therapy
  • World
  • Bayer AG

Location: Hall ##.

  • Breast Cancer
  • Chemotherapy
  • Clinical Trial
  • Hormone
  • Monoclonal Antibody

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## ## Bayer AG ## ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ##

  • Cancer
  • Clinical Trial
  • Hormone
  • Oncology
  • Novartis AG
  • Clinical Trial profile. 1420 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Pharmaceutical
  • Therapy
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Monoclonal Antibody
  • Oncology
  • Prostate Cancer
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

Merck KG ## ## ## ## ## Pfizer Inc Park Active Molecules Pantarhei Bioscience BV Health Ever Bio-Tech Co Ltd ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Ferring Holding SA ## ## ## ## ## AlphaMab Co Ltd ## ## ## ## ## Abbott Laboratories A.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Pharmaceutical
  • Urology

Core operating income was USD ##. ## billion (-##%, +##% cc).

  • Clinical Trial
  • Diagnostics
  • Hormone
  • Immunochemistry Test
  • In Vitro Diagnostic Reagent
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

## ## ## ## ## ## MallInckrodt Plc ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## GlaxoS

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Therapy
  • World
  • 5. All the trials included are unique trials.

## ## ## ## ## ## China ## ## ## ## ## ## ## ## India ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Datab

  • Clinical Trial
  • Hormone
  • World
  • Product Initiative
  • Pfizer Inc.
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

The prominent features of this report are - ##.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Therapy
  • Urology
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • World
  • Bayer AG

In 2015, Zarxio®(filgrastim), launched by Sandoz, became the first biosimilar approved by the US Food and Drug Administration (FDA) under the 2010 Biologics Price Competition and Innovation Act (BPCIA).

  • Clinical Trial
  • Hormone
  • Immunochemistry Test
  • Medical Device
  • Siemens Healthcare GmbH
  • Clinical Trial profile. 71 Trial Title

## ## ## ## ## Novartis AG ## ## ## ## ## ## Merck & Co., Inc. ## ## ## ## ## ## Pfizer Inc. ## ## ## ## ## ## Abbott Laboratories ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## Allergan

  • Clinical Trial
  • Hormone
  • Pharmaceutical
  • World
  • Product Initiative

The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others.

  • Hormone
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Amgen Inc.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • World
  • Pfizer Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • Hospital
  • Neurology

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Hormone
  • Hospital
  • Neurology

The only one big producer is Pfizer Pharmaceutical Co., Ltd.

  • Hormone
  • Pharmaceutical
  • Prostate Cancer
  • China
  • Demand
  • 5. All the trials included are unique trials.

WCE Oral Presentation Details: Date and Time: May ##, 2017 from ##:## to ##:## p. m.

  • Clinical Trial
  • Genitourinary System Disease
  • Hormone
  • Therapy
  • World

Detailed results of RILOMET-## will be submitted for presentation and publication.

  • Hormone
  • Therapy
  • World
  • Product Initiative
  • AnGes MG, Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Hormone
  • Hospital
  • Renal Disease
  • Therapy